Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals flaws in long-read DNA technology
The researchers suggest that data produced by long-read technologies should be interpreted with caution.
Findings suggest that correcting software is unreliable

Researchers at the University of Edinburgh’s Roslin Institute have warned of flawed data from long-read DNA readings.

New technologies that can read long strings of DNA are up to 99.8 per cent accurate.  But in a genome of more than three billion letters, this could equate to millions of errors.

Scientists say that such mistakes could falsely suggest that a person has a genetic make-up that heightens their risk of a certain disease. Data produced by these technologies should, therefore, be interpreted with caution, the team suggests, as it could create problems for analysing genetic information from people and animals.

“Long-read technologies are incredibly powerful but it is clear that we can’t rely on software tools to correct errors in the data – some hands-on expertise may still be required,” explained Professor Mic Watson of the Roslin Institute. “This is important as we increasingly use genomic technologies to understand the world around us.”

Writing in the Nature Biotechnology, the researchers describe an analysis of three recent studies reporting human genome sequences from long-read methods. They found that the data contained thousands of mistakes, even after using corrective software.

The team writes that such errors could have major implications if the methods are used in clinical studies to diagnose patients.

“Long-read technologies are incredibly powerful but it is clear that we can’t rely on software tools to correct errors in the data – some hands-on expertise may still be required,” said Professor Mick Watson, of the University of Edinburgh’s Roslin Institute.

“This is important as we increasingly use genomic technologies to understand the world around us.”

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.